Arrhythmia Research Technology (HRT) appoints Michael S. Gunter, a director, as interim CEO...

|About: Arrhythmia Research Technol... (HRT)|By:, SA News Editor

Arrhythmia Research Technology (HRT) appoints Michael S. Gunter, a director, as interim CEO after current CEO and board member James E. Rouse resigned effective October 26.